Sunanda Lahiri

Biography

 An interdisciplinary scientist with a knowledge of Chemistry, Mass spectroscopy, Protein analytics, Protein-ligand interactions, Cell biology and various instruments and softwares . Passionate to solve complex problems in oncology by understanding their signal transduction pathways and protein engineering techniques which will lead in developing novel cancer drugs. Currently, at Pfizer biosimilars industries, Group lead and Analytical representative for a monoclonal antibody. Extensive experience in developing analytical methods for biosimilars. >PhD from Max Planck Institute for Molecular Physiology, Germany by generating largest Light switchable semisynthetic STAT6 protein variants found in cancer cell lines and membrane protein DGK by EPL and NCL techniques which involves expression of intein fusion proteins and ligation of post translationally modified peptides.  $ Increasing product yields, protein-DNA-protein interaction studies, in vivo (cell biology and microinjection) and in vitro studies.  >Post Doc- Target lead research- GPCR-ligand interaction studies, proteomics from Albert Ludwig Uni,Germany.  @ Dr. Reddy's Laboratories, Biosimilars. Led 2 large teams, Project Management, Method development of protein analysis and raw materials, Strategic planning, Delivery oriented, Recruitment, performance appraisal, Conducting audits, Business stakeholder interactions and collaborations, Documentation and specialized in GMP systems.

Research Interest

 Biotechnology, Bioinformatics, pharmaceutical science